Vaccines and Related Biological Products Advisory Committee – 9/17/2021

November 2, 2021 3:31 pm
Join us for a Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTech’s supplemental Biologics License Application for administration of a third dose, or “booster” dose, of the COVID-19 vaccine, Comirnaty, in individuals 16 years of age and older. Watch live captions here: https://www.captionedtext.com/client/…
Category: News
About The Author
-
Previous

CDC & FDA Okay Booster Shots For Some Americans | The View
Next

FDA Advisory Panel Unanimously Recommends Moderna Booster Shots Against Covid

Related Videos

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

2 FDA Experts Raise Doubts About COVID-19 Booster Shots

2 FDA Experts Raise Doubts About COVID-19 Booster Shots

Virtual Press Conference: COVID-19 Vaccines for Children 5-11 Years Old – 10/29/2021

Virtual Press Conference: COVID-19 Vaccines for Children 5-11 Years Old – 10/29/2021

Andrea Garcia discusses FDA/CDC recommendations on boosters | COVID-19 Update for Oct. 20, 2021

Andrea Garcia discusses FDA/CDC recommendations on boosters | COVID-19 Update for Oct. 20, 2021

CDC, FDA need more time before booster shot rollout l WNT

CDC, FDA need more time before booster shot rollout l WNT

FDA authorizes Pfizer’s COVID-19 vaccine boosters l GMA

FDA authorizes Pfizer’s COVID-19 vaccine boosters l GMA